مجله دانشکده پزشکی اصفهان
پیاپی 644 (هفته چهارم آذر 1400)

Shoulder obstruction syndrome is a common disease of the shoulder joint that causes shoulder pain, especially in adults. In the present study, we aimed to evaluate and compare the effect of a combination of conventional therapies with kinesiotaping on shoulder pain and activity in patients with shoulder obstruction syndrome.

This was a randomized controlled clinical trial study performed on 20 patients with shoulder entrapment syndrome. Patients were assigned to control and intervention treatment groups. For patients in both control (medication and exercise) and intervention (medication, exercise, and kinesiotaping) groups, the same medication was prescribed by a physical therapist, and the same exercise was provided by the physical therapist. Patients 'pain was measured, and patients' shoulder function were compared.</em>

The mean pain score decreased significantly in both groups after treatment (P = 0.003). The mean pain score in the intervention group was significantly lower than the control group (P < 0.001). The mean shoulder function score improved significantly in both groups after treatment (P = 0.007). The mean shoulder performance score in the intervention group was significantly better than the control group (P = 0.003).

The use of kinesiotaping along with exercise and painkillers had significant effects on improving patients' performance and reducing pain.

Intravenous immunoglobulin (IVIG) is a product isolated from the plasma of donors. Laboratory variations are one of the complications of this product. The goal of this study was to evaluate the adverse effects and laboratory variations in children receiving IVIG.

This retrospective cross-sectional study was conducted by studying the file records of all admitted patients receiving IVIG in Imam Hossein Hospital, Isfahan, Iran, in years 2018-2019. Then, all registering data in collection form were entered into SPSS software, and relevant analysis was performed.

Serum sodium, potassium, and hemoglobin reduced significantly. Blood urea nitrogen (BUN) level increased after infusion. However, changes in albumin and creatinine were not statistically significant. 3 patients (16.67%) developed fever, chills, and headache after infusion. No reduction in urinary output, or acute renal failure was observed in any of patients.

The laboratory variations are not clinically dangerous in patients. Follow-up tests are not routinely recommended for all patients.

Acute myocardial ischemia during coronavirus disease 2019 (COVID-19) infection can occur in two forms of acute myocardial infarction type І and II. In acute myocardial infarction type І, infection can cause inflammation, and inflammation causes the secretion and increase of cytokines such as interleukin 1, 6, and 8, as well as tumor necrosis factor (TNF) in the circulation. This mechanism causes the secretion of collagenase from activated macrophages, and the results of these reactions is a precursor to plaque rupture, increased coagulation, and thrombus formation. This mechanism causes acute myocardial infarction type І on atherosclerotic plaque. In these patients, primary percutaneous coronary intervention (PCI) is the treatment of choice, contrary to the initial theory that lytic therapy was the main treatment. In COVID conditions, the primary PCI time increases from 120 minutes to 180 minutes, and if the primary PCI takes more than 180 minutes, then lytic therapy is recommended. In acute myocardial infarction type II, patients usually do not have angina clinically, troponin rises slightly (less than 2 times normal), and do not have electrocardiogram changes as a sign of ischemia. However, patients with coronary heart disease have persistent chest pain with or without myocardial necrosis. During COVID-19 infection, due to release of interleukin, tumor necrosis alpha, and catecholamine, as well as hypoxia, acidosis, hypertension and/or hypotension, oxygen delivery and myocardial oxygen demand become disturbed, so acute myocardial infarction type II may occur. Supportive therapies are performed in these patients, and the treatment of acute underlying disease such as treatment with steroidal anti-inflammatory drugs and antiviral drugs is the main treatment.</div>